Align Technology (ALGN) Projected to Post Earnings on Wednesday

Align Technology (NASDAQ:ALGN) will likely be announcing its Q2 2026 results after the market closes on Wednesday, July 29th. Analysts expect the company to post earnings of $2.62 per share and revenue of $1.0536 billion for the quarter. Investors can check the company’s upcoming Q2 2026 earning results page for the latest details on the call scheduled for Wednesday, July 29, 2026 at 4:30 PM ET.

Align Technology (NASDAQ:ALGN) last posted its quarterly earnings data on Wednesday, April 29th. The medical equipment provider reported $2.58 earnings per share for the quarter, beating analysts’ consensus estimates of $2.26 by $0.32. The firm had revenue of $1.04 billion for the quarter, compared to analysts’ expectations of $1.02 billion. Align Technology had a return on equity of 15.82% and a net margin of 10.50%.The business’s quarterly revenue was up 6.2% on a year-over-year basis. During the same period in the previous year, the firm earned $2.13 EPS. On average, analysts expect Align Technology to post $9 EPS for the current fiscal year and $10 EPS for the next fiscal year.

Align Technology Trading Up 1.4%

Shares of NASDAQ:ALGN opened at $177.50 on Wednesday. The stock has a 50 day moving average of $172.74 and a 200 day moving average of $174.86. The company has a market cap of $12.71 billion, a PE ratio of 29.78, a price-to-earnings-growth ratio of 1.79 and a beta of 1.67. Align Technology has a 12-month low of $122.00 and a 12-month high of $208.30.

Align Technology announced that its board has approved a share repurchase program on Wednesday, April 29th that permits the company to buyback $200.00 million in outstanding shares. This buyback authorization permits the medical equipment provider to reacquire up to 1.6% of its stock through open market purchases. Stock buyback programs are often an indication that the company’s management believes its shares are undervalued.

Wall Street Analysts Forecast Growth

A number of research firms have weighed in on ALGN. Wall Street Zen upgraded shares of Align Technology from a “buy” rating to a “strong-buy” rating in a research report on Saturday, July 4th. BMO Capital Markets began coverage on shares of Align Technology in a research report on Wednesday, July 8th. They set an “outperform” rating and a $209.00 price objective on the stock. Evercore lifted their target price on shares of Align Technology from $200.00 to $220.00 in a research note on Thursday, April 30th. Leerink Partners upped their target price on shares of Align Technology from $225.00 to $230.00 in a report on Thursday, April 30th. Finally, Piper Sandler increased their price target on Align Technology from $220.00 to $235.00 and gave the stock an “overweight” rating in a research note on Tuesday, April 21st. One research analyst has rated the stock with a Strong Buy rating, eight have given a Buy rating and six have assigned a Hold rating to the company. Based on data from MarketBeat, the company presently has an average rating of “Moderate Buy” and an average target price of $206.07.

Institutional Investors Weigh In On Align Technology

A number of institutional investors have recently added to or reduced their stakes in ALGN. Sunbelt Securities Inc. raised its position in shares of Align Technology by 222.4% during the fourth quarter. Sunbelt Securities Inc. now owns 158 shares of the medical equipment provider’s stock valued at $25,000 after buying an additional 109 shares during the last quarter. CYBER HORNET ETFs LLC bought a new position in shares of Align Technology during the second quarter worth $36,000. MUFG Securities EMEA plc bought a new position in shares of Align Technology during the second quarter worth $38,000. Global Retirement Partners LLC grew its stake in Align Technology by 101.8% during the fourth quarter. Global Retirement Partners LLC now owns 230 shares of the medical equipment provider’s stock valued at $36,000 after acquiring an additional 116 shares in the last quarter. Finally, Caitong International Asset Management Co. Ltd grew its stake in Align Technology by 1,773.3% during the third quarter. Caitong International Asset Management Co. Ltd now owns 281 shares of the medical equipment provider’s stock valued at $35,000 after acquiring an additional 266 shares in the last quarter. 88.43% of the stock is owned by hedge funds and other institutional investors.

About Align Technology

Align Technology, Inc (NASDAQ: ALGN) pioneered the use of digital technology in orthodontics through the development of the Invisalign system, a series of clear, removable aligners that provide an alternative to traditional metal braces. Since its founding in 1997 by Zia Chishti and Kelsey Wirth, the Tempe, Arizona–based company has expanded its focus to include intraoral scanners, CAD/CAM software for dental laboratories and comprehensive digital dentistry solutions.

The company’s signature Invisalign system leverages 3D imaging and computer-aided design (CAD) to create customized aligners that gradually reposition teeth, improving patient comfort and treatment predictability.